However, to the best of our knowledge, the effects of SGLT2 inhibitors on the cardiomyocyte electrophysiological properties, especially in response to stimuli other than hyperglycemia, have not been fully elucidated. The gene discussed is SLC5A2; the disease is Hyperglycemia.